Evidence map›Paper›PMID 41504247›Full record

ArticleHaematologica2026

Clinical outcomes of venetoclax combined with hypomethylating agents

Mahmood Aldapt, Yu-Hung Wang, Kashish J Shah, Mobachir El Kettani, James Foran, Mohamed Kharfan-Dabaja, Hemant Murthy, Aref Al-Kali, Mithun V Shah, Hassan Alkhateeb and 12 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Haematologica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Mahmood AldaptDivision of Hematology and Medical Oncology, Mayo Clinic, Jacksonville.
Yu-Hung WangNational Taiwan University Cancer Center, Taipei.
Kashish J ShahDivision of Hematology and Medical Oncology, Mayo Clinic, Jacksonville.
Mobachir El KettaniDivision of Hematology and Medical Oncology, Mayo Clinic, Jacksonville.
James ForanDivision of Hematology and Medical Oncology, Mayo Clinic, Jacksonville.
Mohamed Kharfan-DabajaDivision of Hematology and Medical Oncology, Mayo Clinic, Jacksonville.
Hemant MurthyDivision of Hematology and Medical Oncology, Mayo Clinic, Jacksonville.
Aref Al-KaliDivision of Hematology, Mayo Clinic, Rochester, Minnesota.
Mithun V ShahDivision of Hematology, Mayo Clinic, Rochester, Minnesota.
Hassan AlkhateebDivision of Hematology, Mayo Clinic, Rochester, Minnesota.
Antoine N SalibaDivision of Hematology, Mayo Clinic, Rochester, Minnesota.
William HoganDivision of Hematology, Mayo Clinic, Rochester, Minnesota.
Cecilia Arana YiDivision of Hematology, Mayo Clinic, Phoenix, Arizona.
Lisa SproatDivision of Hematology, Mayo Clinic, Phoenix, Arizona.
Nathan PunwaniDivision of Hematology, Mayo Clinic, Phoenix, Arizona.
Nandita KheraDivision of Hematology, Mayo Clinic, Phoenix, Arizona.
Jeanne PalmerDivision of Hematology, Mayo Clinic, Phoenix, Arizona.
Mark LitzowDivision of Hematology, Mayo Clinic, Rochester, Minnesota.
Ayalew TefferiDivision of Hematology, Mayo Clinic, Rochester, Minnesota.
Naseema GangatDivision of Hematology, Mayo Clinic, Rochester, Minnesota.
Mrinal M PatnaikDivision of Hematology, Mayo Clinic, Rochester, Minnesota. patnaik.mrinal@mayo.edu.
Talha BadarDivision of Hematology and Medical Oncology, Mayo Clinic, Jacksonville. badar.talha@mayo.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41504247
PMCPMC13231094

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.